RonaldShoreMD
Dermatology • Rockville, MDAcne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery
Dermatologist / Ronald N. Shore MD PA
Dr. Shore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4701 Randolph Rd
Suite 201
Rockville, MD 20852Phone+1 301-468-2100
Summary
- Dr. Ronald Shore is a dermatologist in Rockville, MD. He received his medical degree from University of Saskatchewan College of Medicine and has been in practice 47 years. He specializes in acne & rosacea, cosmetic dermatology, and dermatologic surgery and is experienced in dermatologic surgery, cosmetic dermatology, melanoma, particular interests in (1) developing new treatments and diagnostic tests, and (2) serial skin screening to save lives from all skin cancers, and acne and rosacea.
Education & Training
University of Pennsylvania Health SystemResidency, Dermatology, 1971 - 1974
Johns Hopkins UniversityInternship, Internal Medicine, 1970 - 1971
University Saskatchewan Royal HospitalClass of 1970
Certifications & Licensure
MD State Medical License 1977 - 2025
PA State Medical License 1975 - 1978- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- Response to ritlecitinib with or without narrow-band UVB add-on therapy in patients with active nonsegmental vitiligo: results from a phase 2b extension study.Yuji Yamaguchi, Elena Peeva, Roni Adiri, Pranab Ghosh, Lynne Napatalung
Journal of the American Academy of Dermatology. 2024-12-19 - An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo.Anindita Banerjee, Khaled Ezzedine, Ronald Shore, Elena Peeva, Yuji Yamaguchi
The British Journal of Dermatology. 2024-08-14 - 1 citationsRitlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.Yuji Yamaguchi, Elena Peeva, Ester Del Duca, Paola Facheris, Jonathan Bar
Archives of Dermatological Research. 2024-07-18
Press Mentions
Dermcast.tv Dermatology PodcastsMarch 24th, 2016
Professional Memberships
- Fellow
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
